# US 2020/0139050 A1 · Auto-injector with anti-roll features

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0139050 A1
- Document ID: US20200139050A1
- Status: Published application
- Kind: A1
- Application number: 16/626,669
- Filed: 2018-06-29
- Published: 2020-05-07
- Earliest claimed: 2017-06-30
- Assignees: Regeneron Pharmaceuticals, Inc.
- Applicants: Regeneron Pharmaceuticals, Inc.
- Inventors: Courtney NICHOLAS; Scott BARTON; Bart E. BURGESS; Alexei GORALTCHOUK
- Web page: https://patentgrep.com/patent/US20200139050A1

## CPC

- A61M 5/3129: {Syringe barrels (A61M5/3205, A61M5/50 take precedence)}
- A61M 5/3202: {Devices for protection of the needle before use, e.g. caps (A61M5/50 takes precedence; protectors for sharps A61B50/3001)}
- A61M 5/178: Syringes
- A61M 5/20: Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically (A61M5/142 takes precedence)
- A61M 2205/19: Constructional features of carpules, syringes or blisters
- A61M 2205/582: by tactile feedback
- A61M 2205/583: by visual feedback
- A61M 2205/586: Ergonomic details therefor, e.g. specific ergonomics for left or right-handed users
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

The present disclosure relates to a therapeutic agent delivery device with anti-roll features. In one embodiment, a therapeutic agent delivery device may include a tubular body including a first end portion, a second end portion, and a lumen extending between the first end portion and the second portion. An outer surface of the tubular body includes a first opening in communication with the lumen. The outer surface of the tubular body further may include a ledge extending around a periphery of the first opening, and a portion of the ledge closest to the second end portion of the tubular body may be shaped as an arrowhead. The therapeutic agent delivery device also may include a cap configured to engage the second end portion of the tubular body, which may include a curved sidewall extending radially outward. The curved sidewall may include a protrusion.

## Claims

### Claim 1

A therapeutic agent delivery device, comprising:
a tubular body including a first end portion, a second end portion, and a lumen extending between the first end portion and the second portion, wherein an outer surface of the tubular body includes a first opening in communication with the lumen, the outer surface of the tubular body further includes a ledge extending around a periphery of the first opening, and a portion of the ledge closest to the second end portion of the tubular body is shaped as an arrowhead; and
a cap configured to engage the second end portion of the tubular body, wherein the cap includes a central longitudinal axis, a first end having a first cross-sectional dimension, and a second end having a second cross-sectional dimension larger than the first cross-sectional dimension, and wherein the cap further includes a sidewall extending radially outward from the first end to the second end, and wherein the sidewall includes a protrusion.

### Claim 2 (depends on 1)

The therapeutic agent delivery device of claim 1, wherein the therapeutic agent delivery device is an auto-injector.

### Claim 3 (depends on 1)

The therapeutic agent delivery device of claim 1, wherein the lumen is configured to receive a syringe therein.

### Claim 4 (depends on 3)

The therapeutic agent delivery device of claim 3, wherein the syringe includes a volume of the therapeutic agent, and wherein the first opening is configured to permit visualization of the volume of the therapeutic agent.

### Claim 5 (depends on 1)

The therapeutic agent delivery device of claim 1, wherein, when the cap is not engaged with the tubular body, the ledge is configured to restrict rolling of the tubular body.

### Claim 6 (depends on 1)

The therapeutic agent delivery device of claim 1, wherein, when the cap is engaged with the tubular body, only the protrusion is configured to restrict rolling of the therapeutic agent delivery device.

### Claim 7 (depends on 1)

The therapeutic agent delivery device of claim 1, wherein the protrusion includes a plurality of protrusions.

### Claim 8 (depends on 7)

The therapeutic agent delivery device of claim 7, wherein each protrusion of the plurality of protrusions is circumferentially spaced from an adjacent protrusion.

### Claim 9 (depends on 7)

The therapeutic agent delivery device of claim 7, further comprising a recess disposed between adjacent protrusions.

### Claim 10 (depends on 1)

The therapeutic agent delivery device of claim 1, wherein the protrusion includes a first end and a second end, wherein the first end of the protrusion is spaced from the central longitudinal axis of the cap by a first distance, and wherein the second end of the protrusion is spaced from the central longitudinal axis of the cap by a second distance greater than the first distance.

### Claim 11 (depends on 1)

The therapeutic agent delivery device of claim 1, wherein the outer surface of the tubular body further includes a second opening disposed diametrically opposite to the first opening.

### Claim 12

A therapeutic agent delivery device, comprising:
a tubular body including a first end portion, a second end portion, and a central longitudinal axis, wherein an outer surface of the tubular body includes a geometric configuration extending away from the central longitudinal axis, a portion of the geometric configuration is shaped as an arrowhead, and the geometric configuration is configured to restrict rolling of the tubular body; and
a cap configured to engage the second end portion of the tubular body, wherein the cap includes a first end including an opening in communication with an interior of the cap, a second end having an end wall, and a sidewall extending radially outward from the first end to the second end, and wherein the sidewall includes a protrusion configured to restrict rolling of the cap.

### Claim 13 (depends on 12)

The therapeutic agent delivery device of claim 12, wherein the outer surface of the tubular body includes a plurality of geometric configurations, wherein each geometric configuration includes a portion shaped as an arrowhead.

### Claim 14 (depends on 13)

The therapeutic agent delivery device of claim 13, wherein the geometric configurations are circumferentially spaced from one another on the outer surface of the tubular body.

### Claim 15 (depends on 12)

The therapeutic agent delivery device of claim 12, wherein the outer surface of the tubular body includes a window, and wherein the geometric configuration surrounds a portion of the window.

### Claim 16 (depends on 15)

The therapeutic agent delivery device of claim 15, wherein the window permits visualization of an interior of the tubular body.

### Claim 17 (depends on 12)

The therapeutic agent delivery device of claim 12, wherein the sidewall includes a plurality of protrusions circumferentially spaced from one another.

### Claim 18 (depends on 12)

The therapeutic agent delivery device of claim 12, wherein the sidewall includes a recess disposed between adjacent protrusions.

### Claim 19 (depends on 12)

The therapeutic agent delivery device of claim 12, wherein, when the cap is engaged with the tubular body, only the protrusion is configured to restrict rolling of the therapeutic agent delivery device.

### Claim 20 (depends on 12)

The therapeutic agent delivery device of claim 12, wherein, when the cap is not engaged with the tubular body, the ledge is configured to restrict rolling of the tubular body.

### Claim 21 (depends on 1)

The therapeutic agent delivery device of claim 1, wherein the therapeutic agent delivery device contains dupilumab.
